{"text": ["ACR", "2018:", "Lilly", "Announces", "Positive", "Results", "for", "Two", "Phase", "3", "Studies", "of", "Taltz\u00ae", "(ixekizumab)", "in", "Ankylosing", "Spondylitis", "(Radiographic", "Axial", "Spondyloarthritis)"], "created_at": "2018-10-22 19:30:00"}
{"text": ["A", "Preview", "Of", "Eli", "Lilly's", "Q3", "Earnings"], "created_at": "2018-10-22 18:37:23"}
{"text": ["Pfizer:", "Analysts\u2019", "Recommendations", "on", "October", "22"], "created_at": "2018-10-22 18:30:02"}
{"text": ["Pfizer:", "Analysts", "Expect", "Revenue", "Growth", "in", "Q3"], "created_at": "2018-10-22 16:59:18"}
{"text": ["See", "what", "the", "IHS", "Markit", "Score", "report", "has", "to", "say", "about", "Eli", "Lilly", "And", "Co."], "created_at": "2018-10-22 12:00:20"}
